| Date | Title | | | 07/29/10 | Life Technologies Announces Second Quarter 2010 Results; $350 Million Share Repurchase Authorization| Second quarter GAAP revenue of $904 million and non-GAAP revenue of $906 million
Second quarter GAAP earnings per share of $0.58 and non-GAAP earnings per share of $0.91
Free cash flow of $203 million in the second quarter
CARLSBAD, Calif., Jul 29, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ: LIFE) today announced results for its second quarter ending June 30, 2010. Non-GAAP revenue for the second quarter was $906 million, an increase of 8 percent over the $839 million r... |
|  | | 07/13/10 | Asuragen and Life Technologies Launch CE-Marked BCR/ABL1 Quant(TM)
Leukemia Test in Europe| AUSTIN, Texas & CARLSBAD, Calif., Jul 13, 2010 (BUSINESS WIRE) --Asuragen,
Inc. and Life
Technologies Corporation (NASDAQ: LIFE) announced today that they
have achieved CE-marking and commercial launch in Europe of the BCR/ABL1
Quant(TM) Test, Asuragen's clinically validated and cGMP manufactured test
intended to aid clinicians in the monitoring and treatment of
individuals afflicted with chronic myeloid leukemia (CML). Asuragen
manufac... |
| | | 07/08/10 | Life Technologies Sets New Workflow Standard in Detection of Common
Contaminants in Biopharmaceutical Manufacturing| CARLSBAD, Calif., Jul 08, 2010 (BUSINESS WIRE) --Life Technologies Corporation (NASDAQ:LIFE) today announced an
unprecedented program that streamlines the detection of three common
contaminants of mammalian cell culture-based biopharmaceutical
manufacturing. The Applied
Biosystems Cell Culture Rapid Methods Program applies core
technologies from across the company to combine one sample preparation
step with one instrument platform for real-time PCR... |
| | | 07/07/10 | Life Technologies Announces Redemption of 2% Convertible Senior Notes Due 2023| CARLSBAD, Calif., Jul 07, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ: LIFE) announced today that it has given notice of its intention to redeem all of the outstanding 2% Convertible Senior Notes due 2023 (the "2023 Convertible Notes") on August 6, 2010. As of June 30, 2010 there was $349,544,000 in aggregate principal amount of the 2023 Convertible Notes outstanding. The redemption notice provided includes cusips 46185RAF7 and 46185RAJ9.
The 2023 Convertible Notes are conve... |
| | | 07/07/10 | Life Technologies Releases Global Citizenship Report with Product Sustainability Information| Products Now Incorporate Design-for-Environment Principles to Reduce Impact
CARLSBAD, Calif., Jul 07, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, has released its 2009 Global Citizenship Report, highlighting Life Technologies' organization-wide initiatives to be a leading corporate citizen and balance environmental and social issues with its overall mission to shape biological discovery and ultimately improve life.
Feat... |
| | | 07/06/10 | Life Technologies Sets 2nd Quarter 2010 Earnings Release Date for Thursday, July 29, 2010| CARLSBAD, Calif., Jul 06, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ: LIFE) announced today it will report its second quarter 2010 financial results on Thursday, July 29, 2010, before market open. The company will also hold a conference call on the same day at 8:30 a.m. EDT to discuss operating results, as well as future expectations.
The webcast can be accessed through the investor relations page of the Life Technologies website at http://www.lifetechnologies.com. Alternati... |
| | | 06/17/10 | Life Technologies Features Integrated Solutions for Scientists Engaging in Stem Cell Research| CARLSBAD, Calif., Jun 17, 2010 (BUSINESS WIRE) --Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, today announced activities and product launches in concert with the International Society for Stem Cell Research (ISSCR) 8th Annual Meeting that highlight the company's offerings of complete end-to-end solutions for stem cell research. Stem cell research has been shown to be a critical component of regenerative medicine; a basis for identifying drug targe... |
| | | 06/16/10 | UC San Diego, Salk Institute for Biological Studies and Life
Technologies Team to Conduct Cell Transplant Research for ALS| Pre-clinical research could generate proof of principle for future
cell therapies to treat other neurodegenerative diseases, including
spinal cord injury
CARLSBAD, Calif., Jun 16, 2010 (BUSINESS WIRE) --The
University of California, San Diego, The
Salk Institute for Biological Studies and LifeTechnologies Corporation (NASDAQ: LIFE) today announced the
initiation of studies which may lead to the future development of cell
transplant therapy for... |
| | | 06/16/10 | Life Technologies Readies Researchers for Transition From Benchtop to Bedside| Tools and Reagents Pre-Configured to Support Cell Therapy Clinical Translation
CARLSBAD, Calif., Jun 16, 2010 (BUSINESS WIRE) --LifeTechnologies Corporation (NASDAQ:LIFE) today announced the formation of GIBCO(R)Cell Therapy Systems (CTS(TM)), which will offer the life science industry's widest array of products to support cell therapy applications, including regenerative medicine. Specifically designed to help cell therapy practitioners accelerate the transition from research to clinical appli... |
| | | 06/03/10 | New Genomic Cancer Care Alliance Formed to Study Whole-Genome Sequencing in Cancer Treatment| Leading oncology and genomic medicine institutions to sequence patients with broad range of difficult-to-treat cancers
CARLSBAD, Calif., Jun 03, 2010 (BUSINESS WIRE) --Life Technologies Corporation (NASDAQ: LIFE) today announced the creation of the Genomic Cancer Care Alliance to help people battling cancer gain access to treatment options found through analysis of their genomic information. Founding partners include Fox Chase Cancer Center, Scripps Genomic Medicine, and the Translational Geno... |
| | | 06/02/10 | Life Technologies Completes Investment in Synthetic Genomics, Inc.| CARLSBAD, Calif., Jun 02, 2010 (BUSINESS WIRE) --Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, announced today that it has made an equity investment in Synthetic Genomics, Inc. (SGI), a privately held company founded to commercialize synthetic genomic advances. Terms of the investment were not disclosed.
SGI and its founders are world leaders in the design and construction of synthetic genomes, where DNA can be assembled in the laboratory and us... |
| | | 06/02/10 | Life Technologies Partners with German Cancer Research Center to Create World-Class Genome Sequencing Facility| CARLSBAD, Calif. & HEIDELBERG, Germany, Jun 02, 2010 (BUSINESS WIRE) --LifeTechnologies Corporation (NASDAQ: LIFE) and the German Cancer Research Center (Deutsches Krebsforschungszentrum or DKFZ) today announced their collaboration to create the National High-Throughput Sequencing Center. This exclusive partnership will create the largest sequencing facility in Germany and the first national sequencing center in Europe dedicated to systems biology.
The center will operate 10 SOLiD(TM) 4 hq... |
| | | 05/28/10 | Life Technologies Completes Tender Offer for Synthetic Biology Firm Geneart| Establishes Leadership Position in Emerging Field
CARLSBAD, Calif., May 28, 2010 (BUSINESS WIRE) --Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, announced today that it has concluded its tender offer and acquired a majority stake in Geneart AG, the global leader of the synthetic gene market segment. The combination of Geneart with Life Technologies' resources and commercial capabilities creates a well-capitalized synthetic biology company with adv... |
| | | 05/26/10 | Life Technologies Employees Help Communities Around the World During Seventh Annual Global Volunteer Day| Employees Volunteer More Than 12,000 Hours for Local Communities
Follow Efforts Live on Twitter at #LIFEGVD
CARLSBAD, Calif., May 26, 2010 (BUSINESS WIRE) --More than 3,600 employees at Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, today are donating a half day of their time to more than a hundred projects around the globe as part of the company's seventh annual Global Volunteer Day. The company's employees are donating more than 12,000 hours of... |
| | | 05/18/10 | Two New Applied Biosystems Forensic Kits Approved for Use by the National DNA Index System| Enables New Era of Efficiency and Effectiveness for Forensic DNA Laboratories
CARLSBAD, Calif., May 18, 2010 (BUSINESS WIRE) --LifeTechnologies Corporation (NASDAQ:LIFE) today announced that its Applied Biosystems Identifiler(R) Direct and Identifiler(R) Plus forensic kits have been approved by the United States Federal Bureau of Investigation for use by laboratories generating DNA profiles for inclusion in the National DNA Index System (NDIS) CODIS Database. The advanced capabilities of these... |
| | | 05/03/10 | Life Technologies to Present at Baird's 2010 Growth Stock Conference| CARLSBAD, Calif., May 03, 2010 (BUSINESS WIRE) --Life Technologies Corporation (NASDAQ: LIFE) announced today it will present at Baird's 2010 Growth Stock Conference on Thursday, May 20, 2010, at 7:45 a.m. CDT. Greg Lucier, Life Technologies' Chief Executive Officer, will present on behalf of the company. The presentation will be followed by a 20-minute breakout session at 8:15 a.m. CDT. The company will webcast the presentation, which will be available on the Life Technologies' investor relatio... |
| | | 04/27/10 | Life Technologies Announces First Quarter 2010 Results | First quarter GAAP revenue of $885 million and non-GAAP revenue of $887 million
First quarter GAAP earnings per share of $0.48, and non-GAAP earnings per share of $0.87
Free cash flow of $41 million in the first quarter
CARLSBAD, Calif., Apr 27, 2010 (BUSINESS WIRE) --Life Technologies Corporation (NASDAQ: LIFE) today announced results for its first quarter ending March 31, 2010. Non-GAAP revenue for the first quarter was $887 million, an increase of 13 percent over the $785 million reported ... |
| | | 04/26/10 | Life Technologies to Host Investor Day June 2, 2010| CARLSBAD, Calif., Apr 26, 2010 (BUSINESS WIRE) --Life Technologies Corporation (NASDAQ: LIFE) today announced it will be hosting an Investor Day which is being held at the company's headquarters in Carlsbad, California on Wednesday, June 2, 2010 from 9:00 a.m. to 2:00 p.m. PDT. Greg Lucier, Life Technologies' Chairman and Chief Executive Officer, as well as select members of Life Technologies' management team will present on behalf of the company. Presentations will provide information on the co... |
| | | 04/26/10 | Life Technologies Advances Gene Regulation Research With Debut of Life Science Industry's First Benchtop Proteomic and Epigenetic Sample Preparation System| MAGic(TM) Sample Processor Eliminates Manual Methodologies, Increases ProductivityCARLSBAD, Calif., Apr 26, 2010 (BUSINESS WIRE) --LifeTechnologies Corporation (NASDAQ:LIFE) today debuted the life science industry's first benchtop sample preparation system designed to increase productivity while eliminating manual and contamination-related challenges traditionally associated with protein and epigenetic protocols. The Invitrogen MAGic(TM) Sample Processor enables researchers to cut protocol time... |
| | | 04/19/10 | Life Technologies Introduces New Real-Time PCR System| Usability and Performance Enhancements Promote New Era of Lab Productivity
CARLSBAD, Calif., Apr 19, 2010 (BUSINESS WIRE) --Life Technologies Corporation (NASDAQ:LIFE) today announced the expansion of its industry-leading family of real-time PCR systems with the introduction of a new high-productivity instrument. The Applied Biosystems ViiA(TM) 7 Real-Time PCR System seamlessly integrates a variety of quantitative PCR (qPCR) and genotyping applications, enabling researchers to enter a new era ... |
| | | 04/14/10 | Life Technologies Scientists Help Uncover Powerful Predictor of Breast Cancer Progression| New TaqMan Non-coding RNA Assays Enable Discovery of a Novel Molecular Regulator of Metastasis
CARLSBAD, Calif., Apr 14, 2010 (BUSINESS WIRE) --Life Technologies Corporation (NASDAQ: LIFE) today announced that its scientists have teamed with researchers from Stanford University School of Medicine, and other institutions to discover a genomic component that plays a key role in promoting breast cancer progression. A study published today in the journal Nature details how levels of a specific kin... |
| | | 04/07/10 | Life Technologies Announces 2009 Online Annual Report Now Available| CARLSBAD, Calif., Apr 07, 2010 (BUSINESS WIRE) --LifeTechnologies Corporation (NASDAQ: LIFE) today announced the availability of its 2009 online annual report on its corporate website.
The online report, a follow-up to Life Technologies' award-winning 2007 and 2008 video annual reports, is a more sustainable alternative to a printed annual report, and gives investors, customers and employees a more unique, innovative glimpse into the company and its accomplishments in 2009.
Highlights in the... |
| | | 04/06/10 | Life Technologies Sets 1st Quarter 2010 Earnings Release Date for Tuesday, April 27, 2010| CARLSBAD, Calif., Apr 06, 2010 (BUSINESS WIRE) --Life Technologies Corporation (NASDAQ: LIFE) announced today it will report its first quarter 2010 financial results on Tuesday, April 27, 2010, after market close. The company will also hold a conference call on the same day at 4:30 p.m. EDT to discuss operating results.
The webcast can be accessed through the investor relations page of the Life Technologies' website at http://www.lifetechnologies.com. Alternatively, callers may listen to the l... |
| | | 03/24/10 | Life Technologies Gains IVD Mark for Real-Time PCR Instrument| 7500 Fast Dx Real-Time PCR Instrument Meets European Requirements for In Vitro Diagnostic UseCARLSBAD, Calif., Mar 24, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ: LIFE) today announced that its Applied Biosystems 7500 Fast Dx Real-Time PCR Instrument is available as a platform suitable for in vitro diagnostics (IVD) use in Europe. Clinical laboratories from 22 countries and European institutions that develop in vitro molecular diagnostic assays in oncology, genetic disease and... |
| | | 03/23/10 | Life Technologies and the Integrated Biobank of Luxembourg Form Strategic Partnership| Sequencing of Biospecimen Samples to Advance Disease Research
CARLSBAD, Calif. & LUXEMBOURG, Mar 23, 2010 (BUSINESS WIRE) -- During an official visit of the Translational Genomics Research Institute (TGen) by H.R.H. Prince Guillaume, Hereditary Grand Duke of Luxembourg and Jeannot Krecké, Luxembourg's Minister for the Economy & Foreign Trade,LifeTechnologies Corporation (NASDAQ:LIFE) and the Integrated Biobank of Luxembourg (IBBL) today announced a strategic partnership aimed at advanci... |
| | | 03/23/10 | Life Technologies Kit Receives Industry Validation for Detection of Salmonella| Real-Time PCR Workflow Rapidly Identifies Foodborne Pathogen
CARLSBAD, Calif., Mar 23, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ:LIFE) today announced that its Applied Biosystems MicroSEQ(R)Salmonella spp. Detection Kit has been validated by the AOAC Research Institute for detection of the bacteria Salmonella. This validation from one of the world's leading food industry standards organizations is expected to enable more effective monitoring of the food supply for Salmonella... |
| | | 03/17/10 | Life Technologies Named Among Top 100 Best Corporate Citizens| CRO Magazine Ranks Corporate Responsibility Performance of Major Companies Worldwide
CARLSBAD, Calif., Mar 17, 2010 (BUSINESS WIRE) -- LifeTechnologies Corporation (NASDAQ: LIFE) announced that for the first time, CRO Magazine (formerly Corporate Responsibility Magazine) has named the company to its annual 100 Best Corporate Citizens List. The list is one of the world's top corporate responsibility rankings based on publicly-available information and recognized by PR Week as one of America's to... |
| | | 03/10/10 | Scientists Discover Causative Genetic Mutation Associated with Common Inherited Neurological Disorder| Personal Genome Sequencing Identifies Mutation Linked to Charcot-Marie-Tooth Disease
CARLSBAD, Calif., Mar 10, 2010 (BUSINESS WIRE) -- Scientists using advanced genomic analysis technologies from Life Technologies Corporation (NASDAQ: LIFE) have sequenced an individual's genome and identified the specific causative mutation associated with Charcot-Marie-Tooth Disease (CMT), one of the most common inherited neurological disorders currently affecting 1 in 2,500 individuals in the United States.
... |
| | | 03/05/10 | Life Technologies, TGen and US Oncology Partner on Groundbreaking Breast Cancer Sequencing Research| First-of-Its-Kind Project Will Sequence Difficult Breast Cancers to Provide Insight into Treatment Strategies
CARLSBAD, Calif., PHOENIX & THE WOODLANDS, Texas, Mar 05, 2010 (BUSINESS WIRE) -- LifeTechnologies Corporation (NASDAQ:LIFE) today announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies. Th... |
| | | 03/02/10 | Life Technologies Foundation and DNA - PROKIDS Team to Prevent Child Trafficking in Haiti| Efforts Will Help Reunite Haitian Children With Families
CARLSBAD, Calif., Mar 02, 2010 (BUSINESS WIRE) -- The Life Technologies Foundation, a non-profit arm of LifeTechnologies Corporation (NASDAQ:LIFE) and DNA - PROKIDS today announced that DNA samples will be collected in Haiti from parents who have reported their children missing in hopes of reconciling families and combating the trafficking of children. This effort is supported through the Foundation's expanded relationship with DNA - PROK... |
| | | 03/01/10 | Life Technologies Unveils Single Molecule Sequencing Technology| CARLSBAD, Calif., Mar 01, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ:LIFE) today announced early stage results from its single molecule sequencing (SMS) technology. The technology promises to combine virtually unlimited continuous long read lengths with unmatched accuracy to deliver targeted genomic sequence data in a matter of hours, paving the way for sequencing to become a commonplace tool in research laboratories and clinical settings worldwide.
Dr. Joseph Beechem, Chief... |
| | | 02/24/10 | Life Technologies Debuts the SOLiD(TM) PI System, Expands Genetic Sequencing Portfolio| Powerful, cost-effective system to provide highest accuracy sequencing data for range of applications
CARLSBAD, Calif., Feb 24, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ: LIFE) today announced plans for the Applied Biosystems SOLiD(TM) PI System, a new highly accurate, flexible and easy-to-use genomic analysis platform that will bring next-generation sequencing within the grasp of all life science research laboratories worldwide. Early customer adoption of the SOLiD PI Syste... |
| | | 02/23/10 | Life Technologies Launches First Capillary Electrophoresis Sequencing System Designed for Forensic Laboratories| New DNA Platform Validated for Human Identification ApplicationsCARLSBAD, Calif., Feb 23, 2010 (BUSINESS WIRE) -- LifeTechnologies Corporation (NASDAQ:LIFE) today announced the launch of a new genetic analysis system designed to optimize data quality and deliver increased reliability, performance, quality assurance and ease-of-use specifically for forensic DNA testing laboratories. The Applied Biosystems 3500 Series Genetic Analyzer is the latest advancement in the company's industry leading lin... |
| | | 02/22/10 | Life Technologies to Webcast Investor Presentation as Part of the UBS West Coast Bus Tour| CARLSBAD, Calif., Feb 22, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ: LIFE) today announced it will be webcasting management presentations to investors as part of the UBS West Coast Life Sciences Bus Tour which is being held at the company's headquarters in Carlsbad on Monday March 15th at 8:15 AM PST. Greg Lucier, Life Technologies' Chairman and Chief Executive Officer, as well as select members of Life Technologies' management team will present on behalf of the company. The ... |
| | | 02/19/10 | Life Technologies Announces Completion of $1.5 Billion Senior Notes Offering| CARLSBAD, Calif., Feb 19, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ: LIFE) today announced it has completed and settled the previously announced offering of $250 million aggregate principal amount of 3.375% Senior Notes due 2013 at an issue price of 99.953 percent; $500 million aggregate principal amount of 4.400% Senior Notes due 2015 at an issue price of 99.668 percent; and $750 million aggregate principal amount of 6.000% Senior Notes due 2020 at an issue price of 99.796 p... |
| | | 02/18/10 | Life Technologies' SOLiD(TM) System Used in Research on Cancer, Human Genetic Variation| Scientific Papers Highlight Use of Company's Next-Generation Sequencing Platform as Key Tool for Better Understanding of Human Origins and Disease
CARLSBAD, Calif., Feb 18, 2010 (BUSINESS WIRE) -- LifeTechnologies Corporation (NASDAQ:LIFE) today announced the publication of two key scientific papers that highlight the utility of next-generation sequencing instruments in better understanding disease and the genetic differences that cause diversity within and between human populations. The Appl... |
| | | 02/17/10 | Life Technologies to Present at the Cowen and Company 30th Annual Health Care Conference| CARLSBAD, Calif., Feb 17, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ: LIFE) today announced it will present at the Cowen and Company 30th Annual Health Care Conference on Wednesday, March 10, at 9:30 a.m. EST at the Boston Marriott Copley Place. David Hoffmeister, Life Technologies' Chief Financial Officer, will present on behalf of the company. The presentation will be followed by a 35-minute breakout session at 10:15 a.m. EST. The company will webcast the presentation, which... |
| | | 02/02/10 | Life Technologies Responds to Challenge of Detecting Vesivirus 2117 Contamination in Mammalian Cell Culture Manufacturing| New Molecular Test Provides Rapid Sample Preparation and qPCR Method for Specific and Sensitive Detection of This RNA Virus
CARLSBAD, Calif., Feb 02, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ:LIFE) today announced a new molecular test for the detection of Vesivirus 2117, a potential contaminant of mammalian cell culture based biopharmaceutical manufacturing. The Applied Biosystems ViralSEQTM Vesivirus Detection Kit is a highly sensitive and accurate test that enables the q... |
| | | 02/01/10 | Life Technologies Completes Divestiture of Mass Spectrometry Business| CARLSBAD, Calif., Feb 01, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, has completed the previously announced sale of its mass spectrometry business to Danaher Corporation (NYSE: DHR) for $450 million in cash, subject to a conventional working capital adjustment.
Danaher has also acquired Life Technologies' joint venture partner in the business, MDS Analytical Technologies, a division of MDS Inc. (NYSE: MDZ). Mass spect... |
| | | 01/28/10 | Life Technologies and Ignite Institute Partner to Create Largest Next Generation Genomic Sequencing Facility in North America| CARLSBAD, Calif. & FAIRFAX, Va., Jan 28, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ:LIFE) and the Ignite Institute for Individualized Health announced today a collaboration to create a ground-breaking genomic sequencing center at Ignite's new facility in Northern Virginia. Ignite will acquire 100 of the Applied Biosystems SOLiD(TM) 4 Systems, the most advanced next generation DNA sequencing platform on the market, establishing the largest concentration of genetic analytical po... |
| | | 01/28/10 | Life Technologies Announces Fourth Quarter and Fiscal Year 2009 Results| Fourth quarter GAAP earnings per share of $0.26, and non-GAAP earnings per share of $0.80Free cash flow of $187 million in the fourth quarter, and full year free cash flow of $534 million
CARLSBAD, Calif., Jan 28, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ: LIFE) today announced results for its fourth quarter and full year ending December 31, 2009. Non-GAAP revenue for the fourth quarter was $874 million, resulting in full year non-GAAP revenues of $3.30 billion, an increas... |
| | | 01/27/10 | Life Technologies Brings Genomic Sequencing Closer to the Clinic| Company announces SOLiD(TM) 4 System, delivering industry's most cost effective, highest quality genome for $6,000, reduced to $3,000 by end of 2010 with SOLiD(TM) 4hq upgrade
Company introduces BioScope(TM) software solution, announces major investment to address bioinformatics challenges
Life Technologies Foundation announces $5 million in grants to accelerate physician education in molecular medicine
CARLSBAD, Calif., Jan 27, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NAS... |
| | | 01/21/10 | Applied Biosystems Forensic DNA Kit Approved for Use by the National DNA Index System| Addition of DNA Profiles to FBI Database Expected to Increase Links of Potential Suspects to Crimes
CARLSBAD, Calif., Jan 21, 2010 (BUSINESS WIRE) -- Applied Biosystems, part of LifeTechnologies Corporation (NASDAQ:LIFE) today announced that its AmpFℓSTR® MiniFiler™ PCR Amplification Kit has been approved for inclusion in the National DNA Index System (NDIS), a United States Federal Bureau of Investigation database that facilitates the electronic comparison and exchange of DNA profiles betwee... |
| | | 01/12/10 | Life Technologies Signs Definitive Agreement to Acquire AcroMetrix|
Acquisition Adds to Company's Strengths in Molecular Diagnostic Offerings
CARLSBAD, Calif., Jan 12, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ: LIFE), a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire AcroMetrix, for an undisclosed amount.
AcroMetrix is a provider of molecular and serological diagnostic quality control products to clinical laboratories, blood screening centers and in-vitro diagnostic (IV... |
| | | 01/11/10 | Life Technologies Sets 4th Quarter and Full Year 2009 Earnings
Release Date for Thursday, January 28, 2010| CARLSBAD, Calif., Jan 11, 2010 (BUSINESS WIRE) -- Life Technologies Corporation (NASDAQ: LIFE) announced today it will
report its fourth quarter and full year 2009 financial results on
Thursday, January 28, 2010, before market open. The company will also
hold a conference call on the same day at 8:30 a.m. EST to discuss
operating results, as well as future expectations.
The webcast can be accessed through the investor relations page of the
Life Technologi... |
| |
|
